bluebird bio Inc (BLUE)
0.3201
-0.04
(-11.72%)
USD |
NASDAQ |
Nov 15, 14:32
bluebird bio Net Income (TTM): -311.44M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -311.44M |
| March 31, 2024 | -292.84M |
| December 31, 2023 | -204.10M |
| September 30, 2023 | -47.12M |
| June 30, 2023 | -51.91M |
| March 31, 2023 | -89.26M |
| December 31, 2022 | -230.34M |
| September 30, 2022 | -453.86M |
| June 30, 2022 | -594.16M |
| March 31, 2022 | -735.72M |
| December 31, 2021 | -819.38M |
| September 30, 2021 | -864.20M |
| June 30, 2021 | -842.13M |
| March 31, 2021 | -621.89M |
| December 31, 2020 | -618.70M |
| September 30, 2020 | -642.17M |
| June 30, 2020 | -653.46M |
| March 31, 2020 | -827.77M |
| December 31, 2019 | -789.61M |
| September 30, 2019 | -715.28M |
| June 30, 2019 | -654.73M |
| March 31, 2019 | -604.94M |
| December 31, 2018 | -555.62M |
| September 30, 2018 | -523.83M |
| Date | Value |
|---|---|
| June 30, 2018 | -457.16M |
| March 31, 2018 | -382.06M |
| December 31, 2017 | -335.64M |
| September 30, 2017 | -289.78M |
| June 30, 2017 | -288.00M |
| March 31, 2017 | -275.94M |
| December 31, 2016 | -263.51M |
| September 30, 2016 | -239.42M |
| June 30, 2016 | -205.32M |
| March 31, 2016 | -198.27M |
| December 31, 2015 | -166.78M |
| September 30, 2015 | -139.05M |
| June 30, 2015 | -113.16M |
| March 31, 2015 | -62.89M |
| December 31, 2014 | -48.71M |
| September 30, 2014 | -37.25M |
| June 30, 2014 | -26.33M |
| March 31, 2014 | -29.39M |
| December 31, 2013 | -25.32M |
| September 30, 2013 | -26.24M |
| June 30, 2013 | -25.17M |
| March 31, 2013 | -25.15M |
| December 31, 2012 | -23.67M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-864.20M
Minimum
Sep 2021
-47.12M
Maximum
Sep 2023
-510.00M
Average
-618.70M
Median
Dec 2020
Net Income (TTM) Benchmarks
| Perspective Therapeutics Inc | -59.02M |
| Protalix BioTherapeutics Inc | -14.69M |
| Predictive Oncology Inc | -14.04M |
| Spectral AI Inc | -11.12M |
| AIM ImmunoTech Inc | -28.04M |